CoChat

Combination of radiotherapy and vaccination overcomes checkpoint blockade resistance

Open access
Zheng, Wenxin, Skowron, Kinga B., Namm, Jukes P., Burnette, Byron, Fernandez, Christian, Arina, Ainhoa, Liang, Hua, Spiotto, Michael T., Posner, Mitchell C., Fu, Yang-Xin, Weichselbaum, Ralph R. · 2016 · Oncotarget
Cited by 69

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

// Wenxin Zheng 1, 3, * , Kinga B. Skowron 2, 3, * , Jukes P. Namm 2, 3, 4, * , Byron Burnette 1, 3 , Christian Fernandez 1, 3 , Ainhoa Arina 1, 3 , Hua Liang 1, 3 , Michael T. Spiotto 1, 3 , Mitchell C. Posner 2 , Yang-Xin Fu 3, 5 , Ralph R. Weichselbaum 1, 3 1 Department of Radiation and Cellular Oncology, University of Chicago, Chicago, IL, USA 2 Department of Surgery, University of Chicago, Chicago, IL, USA 3 The Ludwig Center for Metastasis Research, University of Chicago, Chicago, IL, USA 4 Department of Surgery, Loma Linda University Health, Loma Linda, CA, USA 5 Department of Pathology, UT Southwestern Medical Center, Dallas, TX, USA * These authors contributed equally to this work Correspondence to: Ralph R. Weichselbaum, email: rrw@radonc.uchicago.edu Yang-Xin Fu, email: yang-xin.fu@utsouthwestern.edu Keywords: checkpoint blockade, T cell infiltration, radiation therapy, vaccination, tumor model Received: April 14, 2016 Accepted: May 20, 2016 Published: June 07, 2016 ABSTRACT The majority of cancer patients respond poorly to either vaccine or checkpoint blockade, and even to the combination of both. They are often resistant to high doses of radiation therapy as well. We examined prognostic markers of immune cell infiltration in pancreatic cancer. Patients with low CD8 + T cell infiltration and high PD-L1 expression (CD8 + T lo PD-L1 hi ) experienced poor outcomes. We developed a mouse tumor fragment model with a trackable model antigen (SIYRYYGL or SIY) to mimic CD8 + T lo PD-L1 hi cancers. Tumors arising from fragments contained few T cells, even after vaccination. Fragment tumors responded poorly to PD-L1 blockade, SIY vaccination or radiation individually. By contrast, local ionizing radiation coupled with vaccination increased CD8 + T cell infiltration that was associated with upregulation of CXCL10 and CCL5 chemokines in the tumor, but demonstrated modest inhibition of tumor growth. The addition of an anti-PD-L1 antibody enhanced the effector function of tumor-infiltrating T cells, leading to significantly improved tumor regression and increased survival compared to vaccination and radiation. These results indicate that sequential combination of radiation, vaccination and checkpoint blockade converts non-T cell-inflamed cancers to T cell-inflamed cancers, and mediates regression of established pancreatic tumors with an initial CD8 + T lo PD-L1 hi phenotype. This study has opened a new strategy for shifting “cold” to hot tumors that will respond to immunotherapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.9915

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 69

Metadata

Authors
Zheng, W., Skowron, K. B., Namm, J. P., Burnette, B., Fernandez, C., Arina, A., Liang, H., Spiotto, M. T., Posner, M. C., Fu, Y.-X., & Weichselbaum, R. R.
Venue
Oncotarget
Published
2016-06-07
Volume
7
Issue
28
Pages
43039-43051
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2416541866
Cited by
69
References
11
FWCI
4.79
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.